Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial

被引：0
|
作者：
Linda Hartman
Linda A. Rasch
Thomas Klausch
Hans W. J. Bijlsma
Robin Christensen
Yvo M. Smulders
Stuart H. Ralston
Frank Buttgereit
Maurizio Cutolo
Jose A. P. Da Silva
Daniela Opris
Jozef Rovenský
Szilvia Szamosi
Leonie M. Middelink
Willem F. Lems
Maarten Boers
机构：
[1] VU University Medical Center,Amsterdam Rheumatology and Immunology Center ARC
[2] VU University Medical Center,Department of Epidemiology and Biostatistics
[3] University Medical Center Utrecht,Department of Rheumatology & Clinical Immunology
[4] The Parker Institute,Musculoskeletal Statistics Unit
[5] Bispebjerg and Frederiksberg Hospital,Department of Internal Medicine
[6] VU University Medical Center,Department of Rheumatology and Clinical Immunology
[7] University of Edinburgh,Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine
[8] Charité – University Medicine Berlin,Reumatologia
[9] University of Genoa,Department of Rheumatology
[10] Faculdade de Medicina e Hospitais da Universidade de Coimbra,undefined
[11] Carol Davila University,undefined
[12] National Institute for Rheumatic Diseases,undefined
[13] Institute of Medicine,undefined
[14] University of Debrecen Faculty of Medicine,undefined
[15] Middelinc,undefined
来源：
Trials | / 19卷
关键词：
Rheumatoid arthritis; Elderly; Prednisolone; Glucocorticoids; Safety; Harm; Benefit; Cost-effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial
    Hartman, Linda
    Rasch, Linda A.
    Klausch, Thomas
    Bijlsma, Hans W. J.
    Christensen, Robin
    Smulders, Yvo M.
    Ralston, Stuart H.
    Buttgereit, Frank
    Cutolo, Maurizio
    Da Silva, Jose A. P.
    Opris, Daniela
    Rovensky, Jozef
    Szamosi, Szilvia
    Middelink, Leonie M.
    Lems, Willem F.
    Boers, Maarten
    TRIALS, 2018, 19
  • [2] Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial
    den Broeder, Alfons A.
    Verhoef, Lise M.
    Fransen, Jaap
    Thurlings, Rogier
    van den Bemt, Bart J. F.
    Teerenstra, Steven
    Boers, Nadine
    den Broeder, Nathan
    van den Hoogen, Frank H. J.
    TRIALS, 2017, 18
  • [3] Patients' and rheumatologists' perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA study
    Santiago, T.
    Voshaar, M.
    de Wit, M.
    Carvalho, P. D.
    Buttgereit, F.
    Cutolo, M.
    Paolino, S.
    Castelar Pinheiro, G. R.
    Boers, M.
    Da Silva, J. A. P.
    RHEUMATOLOGY, 2021, 60 (07) : 3334 - 3342
  • [4] Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial
    Alfons A. den Broeder
    Lise M. Verhoef
    Jaap Fransen
    Rogier Thurlings
    Bart J. F. van den Bemt
    Steven Teerenstra
    Nadine Boers
    Nathan den Broeder
    Frank H. J. van den Hoogen
    Trials, 18
  • [5] Intradermal acupuncture for rheumatoid arthritis: study protocol for a randomised controlled trial
    Huifang Luo
    Jie Peng
    Qing Ma
    Zhihua Wei
    Changsong Lin
    Mingying Zhang
    Peiwu Li
    Yang Song
    Xiangwei Yang
    Trials, 22
  • [6] Incident Comorbidity Among Patients with Rheumatoid Arthritis Treated or Not with Low-dose Glucocorticoids: A Retrospective Study
    Mazzantini, Maurizio
    Talarico, Rosaria
    Doveri, Marica
    Consensi, Arianna
    Cazzato, Massimiliano
    Bazzichi, Laura
    Bombardieri, Stefano
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (11) : 2232 - 2236
  • [7] Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial
    Mariette, Xavier
    Rouanet, Stephanie
    Sibilia, Jean
    Combe, Bernard
    Le Loet, Xavier
    Tebib, Jacques
    Jourdan, Rosemary
    Dougados, Maxime
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (08) : 1508 - 1514
  • [8] Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial
    Boers, Maarten
    Hartman, Linda
    Opris-Belinski, Daniela
    Bos, Reinhard
    Kok, Marc R.
    Da Silva, Jose A. P.
    Griep, Eduard N.
    Klaasen, Ruth
    Allaart, Cornelia F.
    Baudoin, Paul
    Raterman, Hennie G.
    Szekanecz, Zoltan
    Buttgereit, Frank
    Masaryk, Pavol
    Klausch, L. Thomas
    Paolino, Sabrina
    Schilder, Annemarie M.
    Lems, Willem F.
    Cutolo, Maurizio
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (07) : 925 - 936
  • [9] Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial
    Martin, Naomi H.
    Ibrahim, Fowzia
    Tom, Brian
    Galloway, James
    Wailoo, Allan
    Tosh, Jonathan
    Lempp, Heidi
    Prothero, Louise
    Georgopoulou, Sofia
    Sturt, Jackie
    Scott, David L.
    TRIALS, 2017, 18
  • [10] Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial
    Hartman, L.
    El Alili, M.
    Cutolo, M.
    Opris, D.
    Da Silva, Jap
    Szekanecz, Z.
    Buttgereit, F.
    Masaryk, P.
    Bos, R.
    Kok, M. R.
    Paolino, S.
    Coupe, V. M. H.
    Lems, W. F.
    Boers, M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 57
12345